Overview The National Science Foundation (NSF) is proposing a significant change to the policy framework that governs how researchers and institutions apply for and manage…
Overview The National Science Foundation (NSF) is proposing a significant change to the policy framework that governs how researchers and institutions apply for and manage…
Season 4 – Episode 8 – Student Success Starts with Purpose: Strategies for Supporting First-Year Students This episode discusses how colleges and universities can help…
Season 1 – Episode 47 – AI and Software in Research: When FDA Rules Apply Discusses regulatory considerations for research involving medical devices, particularly given…
“What CITI Program is Reading” is our biweekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
Introduction On June 3, 2026, the International Council for Harmonisation (ICH) finalized Annex 2 of E6(R3), completing the modernization of Good Clinical Practice (GCP). While…
Season 4 – Episode 7 – The Future of Higher Education: A CEO’s View on Workforce Readiness, AI, and Research This episode explores several major…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
“CITI Program Funding Finds” is our monthly blog series which highlights opportunities relevant to research grants, funding, programs open to new applicants, and more. Follow…
Overview The federal government has issued a new government-wide policy establishing funding prohibitions, review requirements, institutional responsibilities, and enforcement mechanisms for certain high-risk life sciences…
“What CITI Program is Reading” is our biweekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
Overview The U.S. Food and Drug Administration (FDA) has issued a revised draft guidance for industry titled Demonstrating Substantial Evidence of Effectiveness for Human Drug…
Overview The U.S. Food and Drug Administration (FDA) has issued a revised draft guidance, Master Protocols for Drug and Biological Product Development, providing updated recommendations…